Novavax's application to Europe and the United States for emergency authorization to use the Coronavirus vaccine has been postponed to the third quarter.

Korean companies are preparing the information required for the application for emergency authorization to use the vaccine. The Ministry of Food and Drug Safety will accept the relevant information and review it promptly.